Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Ambry's ExomeNext; PartnersHealthCare's VariantWire

Premium

Ambry Genetics has launched ExomeNext and ExomeNext-Rapid. The new assays feature faster turnaround times, reduced pricing, and more comprehensive coverage than Ambry's previous exome offering. ExomeNext has a list price of $5,800 with an eight to 12-week turnaround time, while ExomeNext-Rapid has a list price of $15,129 with a two to five-week turnaround time.


Partners HealthCare and GeneInsight have launched VariantWire, a clinical consortium offering clinical laboratories in the US and Canada the ability to share genetic testing data. VariantWire leverages a crowdsourcing mechanism to help laboratories interpret the significance of genetic variants. Founding members include: Partners HealthCare Laboratory for Molecular Medicine, ARUP Laboratories, and Mount Sinai Genetic Testing Laboratory at Icahn School of Medicine in New York. The Mount Sinai Hospital in Toronto and the Canadian Open Genetics Registry have also joined.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.